Transglutaminase 2 (TG2) inhibitors
US12152026B2 · kind B2 · utility
0Cited by
8References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2019 |
| Grant date | Nov 26, 2024 |
| Priority date | — |
| Expiry date | Dec 4, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06139
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit transglutaminase 2 (TG2). Also described herein are methods for using such TG2 inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from TG2 inhibition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.